CVS Health (CVS) financial statements
+426.7%since 2007
- FY2025 revenue
- $402.1B▲ +7.8%
- FY2025 net income
- $1.8B▼ −61.7%
- FY2025 diluted EPS
- $1.39▼ −62.0%
- FY2025 free cash flow
- $7.8B▲ +23.4%
CVS Health income statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 402,067 | 372,809 | 357,776 |
| Operating income | 4,660 | 8,516 | 13,743 |
| Pretax income | 2,136 | 6,148 | 11,173 |
| Net income | 1,768 | 4,614 | 8,344 |
| Diluted earnings per share | 1.39 | 3.66 | 6.47 |
CVS Health balance sheet
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents | 8,453 | 8,884 | 8,196 |
| Total assets | 253,538 | 253,215 | 249,728 |
| Total liabilities | 178,156 | 177,485 | 173,092 |
| Total equity | 75,382 | 75,730 | 76,636 |
| Long-term debt | 60,502 | 60,527 | 58,638 |
CVS Health cash flow statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 10,639 | 9,107 | 13,426 |
| Capital expenditure | -2,832 | -2,781 | -3,031 |
| Free cash flow (derived) | 7,807 | 6,326 | 10,395 |
| Dividends paid | -3,397 | -3,373 | -3,132 |
| Share repurchases | 0 | -3,023 | -2,012 |
Quarterly highlights
| USD millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 108,399 | 106,096 | 100,426 | 105,693 |
| Operating income (derived) | 3,566 | 4,703 | 4,680 | 2,112 |
| Net income (derived) | 2,172 | 2,995 | 2,957 | 2,943 |
| Diluted earnings per share | 1.68 | 2.31 | 2.30 | n/a |
| Operating cash flow (derived) | 4,724 | 6,345 | 4,249 | 3,390 |
| Total assets | 258,075 | 253,768 | 252,974 | 253,538 |
CVS Health major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | 8.3% | 105,292,588 | 16 July 2025 |
| Vanguard Capital Management | 7.5% | 95,598,528 | 29 April 2026 |
| Capital World Investors | 5.5% | 68,785,990 | 13 May 2025 |
CVS Health 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 4 November 2026 | 10-Q | Quarterly report | Quarterly report |
| 4 November 2026 | 8-K | Current report | Current report |
| 4 November 2026 | 8-K | Current report | Current report |
| 17 August 2026 | 8-K | Current report | Current report |
| 5 August 2026 | 10-Q | Quarterly report | Quarterly report |
| 5 August 2026 | 8-K | Current report | Current report |
| 18 May 2026 | 8-K | Current report | Current report |
| 6 May 2026 | 10-Q | Quarterly report | Quarterly report |
Common questions
What was CVS Health's revenue in fiscal 2025?
CVS Health reported $402.1 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 7.8% from fiscal 2024.
What was CVS Health's net income in fiscal 2025?
CVS Health reported net income of $1.8 billion for fiscal 2025, the year ended 31 December 2025, down 61.7% from fiscal 2024. Diluted earnings per share were $1.39.
What was CVS Health's free cash flow in fiscal 2025?
CVS Health had $7.8 billion in free cash flow in fiscal 2025. Operating cash flow was $10.6 billion and capital expenditure was $2.8 billion.
What were CVS Health's total assets at the end of fiscal 2025?
CVS Health reported total assets of $253.5 billion at the end of fiscal 2025, the year ended 31 December 2025.
How much CVS Health history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.